Characterization and use of the NSC-34 cell line for study of neurotrophin receptor trafficking.
about
P1343
Rnf165/Ark2C enhances BMP-Smad signaling to mediate motor axon extensionThe spinal muscular atrophy disease protein SMN is linked to the Golgi networkChondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophyDownregulation of MicroRNA-193b-3p Promotes Autophagy and Cell Survival by Targeting TSC1/mTOR Signaling in NSC-34 Cells.Direct interactions of adaptor protein complexes 1 and 2 with the copper transporter ATP7A mediate its anterograde and retrograde traffickingAlsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicityα-COP binding to the survival motor neuron protein SMN is required for neuronal process outgrowthAberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43)NSC-34 Motor Neuron-Like Cells Are Unsuitable as Experimental Model for Glutamate-Mediated Excitotoxicity.Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions.Analysis of Signaling Endosome Composition and Dynamics Using SILAC in Embryonic Stem Cell-Derived Neurons.Deep proteomic evaluation of primary and cell line motoneuron disease models delineates major differences in neuronal characteristics.Differentiated NSC-34 cells as an in vitro cell model for VX.Down-regulation of apurinic/apyrimidinic endonuclease 1 (APE1) in spinal motor neurones under oxidative stress.Altered astrocytic response to activation in SOD1(G93A) mice and its implications on amyotrophic lateral sclerosis pathogenesis.Regulation of choline acetyltransferase expression by 17 β-oestradiol in NSC-34 cells and in the spinal cord.A novel approach for targeted delivery to motoneurons using cholera toxin-B modified protocells.Non-viral gene therapy that targets motor neurons in vivo.Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosisExpression of functional alternative telomerase RNA component gene in mouse brain and in motor neurons cells protects from oxidative stress.Sphingosine-1-Phosphate and the S1P3 Receptor Initiate Neuronal Retraction via RhoA/ROCK Associated with CRMP2 Phosphorylation.Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model.Conditioned medium from human gingival mesenchymal stem cells protects motor-neuron-like NSC-34 cells against scratch-injury-induced cell death.
P2860
Q24338922-C6951B84-7482-45F1-B488-DAB9ECB69C46Q27329644-03F74D05-A4BA-4817-9F66-96C56ECF8173Q28506113-9E03E38B-D446-45C7-B6B7-1B708BB138D4Q33736536-32AAAE4D-5C44-40F2-B7B0-83D8838B407BQ35253046-ADAABB0E-CC95-4DFB-8B53-040D194AE150Q35562672-138E25C4-3961-4798-A5CC-012ED8864B5DQ36331590-47C90E32-DE4A-46A5-9AEF-3B8899ED5CD2Q36873601-27ED8F8C-B6BA-45B7-8DF1-4545F333D7D4Q36881384-567B292D-3BBE-4606-8C94-CC3A230D1DF3Q36934643-F4D42425-9CCD-452C-921A-FFAB4EC63A29Q38453391-9547F1D2-3C29-4E2A-9375-028985A7CAD8Q38959386-975D4292-1B5F-40BC-A2A3-FD2BF4B0A70EQ38973364-62405D17-A677-4903-9726-89A988C5398AQ39133838-D3ABB761-9B3A-463D-B174-66B3BC87DFB6Q39217922-4A03D728-FF31-4152-B6D0-733BFC321391Q39500722-A6025AE4-E9F1-41CC-AF10-5224544621A9Q41542370-7699E22C-8EE9-49D8-8AD8-B0ABE36677D3Q41760723-3A9C3CFF-245F-4E39-AEFF-EFDF1B65349AQ41875894-AC5C5DF7-170B-4D22-B1E5-5BAA2871999DQ41917031-EA2AEB9A-EDD1-45CE-8684-947D2E0148ADQ42700486-3AC71B47-AECD-4269-A275-E36A9FADCA7FQ45881781-FA9908F8-6528-439E-9606-3D05EE88D8EDQ47400487-23118A32-587B-44A2-8B99-A6D539F14C93
P2860
Characterization and use of the NSC-34 cell line for study of neurotrophin receptor trafficking.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Characterization and use of th ...... otrophin receptor trafficking.
@en
type
label
Characterization and use of th ...... otrophin receptor trafficking.
@en
prefLabel
Characterization and use of th ...... otrophin receptor trafficking.
@en
P356
P1476
Characterization and use of th ...... rotrophin receptor trafficking
@en
P2093
Matthew P Fenech
Robert A Rush
P304
P356
10.1002/JNR.21507
P4510
P577
2008-02-01T00:00:00Z